APAF1 and colorectal carcinoma: miR-23a antisense enhanced 5-fluorouracil chemosensitivity in CRC cells, by acting on the APAF1/Caspase-9 apoptotic pathway (386), while miR-23a over-expression provided 5-FU resistance in a subtype of CRC (387).